Biotech Startups

Majorelle is a French pharmaceutical laboratory that develops treatments, medical devices, and health products across three therapeutic areas: women's health, urology, and family health. It focuses on prevention, protection, and quality of care, aiming to make its products broadly accessible to patients.

1 investor

Labstep provides an electronic lab notebook and research data management platform for scientific and laboratory teams. The company operates in the biotech/research software space.

1 investor

LabyRx develops therapeutic cancer vaccines based on Labyrinthin, a protein target found on adenocarcinoma cells, using synthetic peptide immunotherapy to train the immune system to attack tumors. The company, an immuno-oncology biotech, also pursues monoclonal antibody drug development and combination treatments for patients with adenocarcinomas.

1 investor

Lactalogics develops human milk-based nutrition products for premature and at-risk infants, serving settings from the NICU to at-home care. It also operates a program connecting mothers with excess breast milk to babies in need.

1 investor

LAM-X develops nanofiber materials using patented light-activated photosensitizer technology that generates reactive oxygen species to kill microorganisms, applied to antimicrobial textiles and medical devices such as intravenous catheter dressings. It also produces life science products including a biodegradable universal Western Blot membrane (VerdiBlot) for protein analysis, with applications spanning medical devices, food packaging, crop protection, and water filtration.

1 investor

LAM-X develops advanced nanofiber and polymer materials, including light-activated antimicrobial textiles and Western Blot membranes, for applications in medical devices, food packaging, crop protection, water filtration, and life science research. Its patented technology uses photosensitizers in polymer nanofibers to destroy microorganisms when activated by visible light.

1 investor

Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions. A spin-off from INSERM and the University of Strasbourg's Regenerative Nanomedicine unit, it has EMA and ANSM authorization for a Phase I clinical trial in Strasbourg, France.

1 investor

1 investor

Lantheus is a radiopharmaceutical company that develops, manufactures, and commercializes radiodiagnostics and radiotherapeutics for cancer detection, treatment and monitoring, as well as precision diagnostics for non-oncologic diseases.

1 investor

Laprophan is a Moroccan pharmaceutical company that develops, manufactures, and markets over 1,000 drug references across eight therapeutic areas, operating the country's first pharmaceutical R&D center. It sells products in more than 50 countries and holds international patents, with a focus on accessible therapeutic solutions.

1 investor

Lara DaTx is a company focused on developing targeted treatments for unmet medical needs.

1 investor

Lario Therapeutics develops first-in-class precision medicines aimed at disease-modifying treatments for severe neurological disorders, including developmental and epileptic encephalopathies and Parkinson's disease. Its pipeline is built on genetically validated targets, focusing on early childhood syndromes and adult neurodegenerative conditions.

1 investor

Latent Knowledge builds LitView, a semantic search and knowledge-graph tool that lets researchers search and reason over biomedical literature as a connected network of papers rather than a keyword-ranked list. It serves academic and enterprise research teams with features for field orientation, novelty validation, evidence-cited synthesis, and keeping literature reviews current.

1 investor

Lattice Medical, a spin-off from the Lille University Hospital and University of Lille, develops tissue-engineering technology for autologous soft-tissue regeneration, with a first application in breast reconstruction. Its patented bioresorbable implant aims to replace silicone implants for patients undergoing breast reconstruction.

1 investor

Laurent Pharmaceuticals is a clinical-stage pharmaceutical company focused on drug development. It works on therapeutic candidates through clinical development programs.

1 investor

Laurus Bio, a subsidiary of Laurus Labs, is a biomanufacturing company using precision fermentation and recombinant DNA technology to produce animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements. It serves the biopharma, cultured meat, and cell-culture markets and offers CDMO precision fermentation services to protein companies and bio-manufacturers across healthcare, food, nutrition, personal care, and bio-based materials.

1 investor

Laurus Labs is a pharmaceutical company that manufactures active pharmaceutical ingredients (APIs) and runs R&D and biotech operations, including a Laurus Bio unit. It operates FDA-audited API manufacturing facilities and is a publicly listed company reporting quarterly financial results.

1 investor

LeafWorks conducts plant genomics research linking genotypes to agriculturally and commercially relevant traits, and develops DNA-based tests and services for genetic identification of botanical species. It serves clients in the natural products industry, offering services that support risk mitigation, supply-chain transparency, and modern plant breeding.

1 investor

Oncology company developing targeted and immuno-oncology therapeutics; lead candidate DKN-01 targets the DKK1 protein.

1 investor

Leapfrog Bio is an oncology therapeutics company that uses its Precision PGx Platform to identify and develop targeted cancer treatments, focusing on patients with loss-of-function mutations through synthetic lethality and pharmacogenomic screening.

1 investor

Leap Therapeutics develops targeted and immunotherapy-based cancer treatments, including monoclonal antibodies in clinical development for esophagogastric, gynecologic, colorectal, gastric, and pancreatic cancers.

1 investor

Legacy Health Strategies partners with pharmaceutical and medical device companies to incorporate patient perspectives into product development and clinical trials. The company serves the biopharma and healthcare industries, specializing in patient and community engagement, clinical trial transparency, and patient-centered innovation.

1 investor

Leinco Technologies manufactures antibodies and proteins, offering both large- and small-scale IVD antibody and protein production along with CDMO services for scientists in life sciences discovery, biopharmaceutical, and diagnostics segments. Its reagents support research in areas such as cancer, infectious diseases, and immunology.

1 investor

Lemna Bio develops computational biology and deep learning tools to predict and explain biomolecular interactions. The company targets researchers and partners working on molecular discovery problems across life sciences.

1 investor